Research Paper Volume 16, Issue 2 pp 1733—1749
Identification and validation of methylation-CpG prognostic signature for prognosis of hepatocellular carcinoma
Figure 7. Inhibition of HCC cell proliferation by BMPER overexpression. (A) GO biological process pathway enrichment analysis using GSEA. (B) Confirmation of BMPER overexpression in Hep3B cell line using western blotting. (C) Effects of BMPER overexpression on cell proliferation assessed by MTT assays. (D) Clonal formation assays comparing the LV-NC and LV-BMPER groups.